EBIT at other companies
Other financials
Where this comes from
Calculated from Design Therapeutics, Inc.’s reported figures.
The official record: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Design Therapeutics, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Design Therapeutics, Inc.'s EBIT?
- Design Therapeutics, Inc. (DSGN) reported EBIT of -$19.71M in Q1 2026.
- How has Design Therapeutics, Inc.'s EBIT changed year-over-year?
- Design Therapeutics, Inc.'s EBIT increased by 3.5% year-over-year, from -$20.42M to -$19.71M.
- What is the long-term trend for Design Therapeutics, Inc.'s EBIT?
- Over 4 years (2021 to 2025), Design Therapeutics, Inc.'s EBIT has grown at a 22.0% compound annual growth rate (CAGR), from -$35.83M to -$79.47M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.